311 related articles for article (PubMed ID: 35353440)
1. Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity.
Zarnegar-Lumley S; Stone CA; Smith CM; Hall LL; Luck KE; Koo G; Plager JH; Phillips EJ; Friedman DL
Pediatr Blood Cancer; 2022 Jul; 69(7):e29686. PubMed ID: 35353440
[TBL] [Abstract][Full Text] [Related]
2. Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase.
Mark C; Gupta S; Punnett A; Upton J; Orkin J; Atkinson A; Clarke L; Heisey A; McGovern C; Alexander S
Pediatr Blood Cancer; 2021 Nov; 68(11):e29295. PubMed ID: 34398511
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus Disease 2019 mRNA Vaccination Appears Safe in Pediatric Patients With Hypersensitivity to Polyethylene Glycolated Escherichia coli L-asparaginase.
Wolfset N; Pashmineh Azar AR; Phillips CA; Stein M; Rheingold SR; Heimall J; Elgarten CW
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e202-e204. PubMed ID: 38181327
[TBL] [Abstract][Full Text] [Related]
4. Safety of mRNA vaccination for COVID-19 in children with polyethylene glycol (PEG)-asparaginase allergy.
Doyle R; Melo M; Teoh C; Wen S; Willcocks S
Pediatr Allergy Immunol; 2023 Mar; 34(3):e13939. PubMed ID: 36974643
[No Abstract] [Full Text] [Related]
5. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
[TBL] [Abstract][Full Text] [Related]
6. Successful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy.
Cha B; Kwon KS; Lee HL; Kim CW
J Korean Med Sci; 2022 Aug; 37(32):e251. PubMed ID: 35971765
[TBL] [Abstract][Full Text] [Related]
7. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.
Erdeljic Turk V
Clin Immunol; 2021 Jun; 227():108748. PubMed ID: 33932618
[TBL] [Abstract][Full Text] [Related]
8. Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine.
Hurst M; Jordan A; Capstick J; Brewerton M; Cockroft R; Ingram J
Intern Med J; 2022 Oct; 52(10):1818-1820. PubMed ID: 36000384
[TBL] [Abstract][Full Text] [Related]
9. Polyethylene Glycol Allergy and Immediate-Type Hypersensitivity Reaction to COVID-19 Vaccination: Case Report.
Habran M; Vandebotermet M; Schrijvers R
J Investig Allergol Clin Immunol; 2022 Jun; 32(3):234-235. PubMed ID: 34309514
[No Abstract] [Full Text] [Related]
10. Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate.
Hartono SP; Sharma HP; Bundy V; Thompkins JD; Kochis SR; Brooks JP
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2172-2175.e1. PubMed ID: 35842413
[No Abstract] [Full Text] [Related]
11. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.
Brockow K; Mathes S; Fischer J; Volc S; Darsow U; Eberlein B; Biedermann T
Allergy; 2022 Jul; 77(7):2200-2210. PubMed ID: 34806775
[TBL] [Abstract][Full Text] [Related]
12. Vaccine allergy: evidence to consider for COVID-19 vaccines.
Nilsson L; Csuth Á; Storsaeter J; Garvey LH; Jenmalm MC
Curr Opin Allergy Clin Immunol; 2021 Aug; 21(4):401-409. PubMed ID: 34091550
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics.
Otani IM; Tsao LR; Tang M
Ann Allergy Asthma Immunol; 2022 Jul; 129(1):88-94.e1. PubMed ID: 35288274
[TBL] [Abstract][Full Text] [Related]
14. Vaccines against SARS-CoV-2 are safe to administer in patients with antibodies to pegaspargase.
Swanson HD; Hakim H; Hijano DR; Morton T; Cross S; Inaba H; Jeha S; Pui CH; Karol SE
Cancer Med; 2023 Jan; 12(2):1552-1555. PubMed ID: 35837830
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to SARS-CoV-2 mRNA Vaccination in a Patient With Challenge-Confirmed PEG 2000 Allergy.
Faihs V; Bent R; Darsow U; Biedermann T; Brockow K
J Investig Allergol Clin Immunol; 2023 Apr; 33(2):149-150. PubMed ID: 35638391
[No Abstract] [Full Text] [Related]
16. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients.
Sellaturay P; Gurugama P; Harper V; Dymond T; Ewan P; Nasser S
Clin Exp Allergy; 2022 Jan; 52(1):12-17. PubMed ID: 34822190
[TBL] [Abstract][Full Text] [Related]
17. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines.
Mouri M; Imamura M; Suzuki S; Kawasaki T; Ishizaki Y; Sakurai K; Nagafuchi H; Matsumura N; Uchida M; Ando T; Yoshioka K; Ooka S; Sugihara T; Miyoshi H; Mori M; Okada T; Yamaguchi M; Kunishima H; Kato M; Kawahata K
Allergol Int; 2022 Oct; 71(4):512-519. PubMed ID: 35718709
[TBL] [Abstract][Full Text] [Related]
18. Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine.
Sellaturay P; Nasser S; Islam S; Gurugama P; Ewan PW
Clin Exp Allergy; 2021 Jun; 51(6):861-863. PubMed ID: 33825239
[No Abstract] [Full Text] [Related]
19. The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines.
Bigini P; Gobbi M; Bonati M; Clavenna A; Zucchetti M; Garattini S; Pasut G
Nat Nanotechnol; 2021 Nov; 16(11):1169-1171. PubMed ID: 34732846
[No Abstract] [Full Text] [Related]
20. Hypersensitivity to polyethylene glycol (PEG).
Czarnobilska M; Bulanda M; Kurnik-Łucka M; Gil K
Folia Med Cracov; 2021 Dec; 61(4):55-69. PubMed ID: 35180202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
